{
  "pmcid": "12249832",
  "sha256": "5d9b6af893a490c1e7649907534ba3565e5ac606b6fc9bf81017d7d546ec13c4",
  "timestamp_utc": "2025-11-09T22:19:43.985574+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 11.740434782608698,
    "reading_ease": 27.926304347826118,
    "word_count": 220
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Feasibility of Systemic Lidocaine Infusion in Surgical ICU: A Pilot Study"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "single-center, prospective, single-arm pilot trial"
      },
      "Participants": {
        "score": 2,
        "evidence": "Twelve adult patients admitted after open abdominal surgery were enrolled."
      },
      "Intervention": {
        "score": 2,
        "evidence": "A low-dose lidocaine infusion (10–30 mcg/kg/min) was initiated within 1 hour of ICU admission."
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was feasibility, assessed through recruitment, retention, and withdrawal rates over a 6-month period."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Eighteen participants were screened, with 12 completing the study"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "12 completing the study, resulting in a 66.7% retention rate"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Pain scores decreased by 1.09 units per day (β = −1.09; 95% CI: −1.82 to −0.36; p = 0.003)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No serious adverse events were reported. Dizziness and hypertension were the most common adverse events, affecting 16.7% of patients each."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT06725485."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 14,
    "max_score": 25
  }
}